Abstract
Purpose
Over the past several decades, there has been a reported increase in the incidence of thyroid cancer in many countries. We previously reported an increase in thyroid cancer incidence across continents between 1973 and 2002. Here, we provide an update on the international trends in thyroid cancer between 2003 and 2007.
Methods
We examined thyroid cancer incidence data from the Cancer Incidence in Five Continents (CI5) database for the period between 1973 and 2007 from 24 populations in the Americas, Asia, Europe, Africa and Oceania, and report on the time trends as well as the distribution by histologic type and gender worldwide.
Results
The incidence of thyroid cancer increased during the period from 1998–2002 to 2003–2007 in the majority of populations examined, with the highest rates observed among women, most notably in Israel and the United States SEER registry, at over 14 per 100,000 people. This update suggests that incidence is rising in a similar fashion across all regions of the world. The histologic and gender distributions in the updated CI5 are consistent with the previous report.
Conclusions
Our analysis of the published CI5 data illustrates that the incidence of thyroid cancer increased between 1998–2002 and 2003–2007 in most populations worldwide, and rising rates continue in all regions of the world.
Similar content being viewed by others
References
Forman D, Bray F, Brewster D, Gombe Mbalawa C, Kohler B, Pineros M, Steliarova-Focher E, Swaminathan R, Ferlay J (2014) Cancer Incidence in Fve Continents vol X. No. 164. IARC Scientific Publications, Lyon
Ahn H, Kim H, Welch G (2014) Korea’s thyroid-cancer “epidemic”—screening and over diagnosis. N Engl J Med 371:1765–1776
American Cancer Society (2018) Cancer facts & figures. American Cancer Society. https://www.cancer.org/content/dam/cancer-orwww.cancer.org/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdfg/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf. Accessed 8 March 2018
Bann DV, Goyal N, Camacho F, Goldenberg D (2014) Increasing incidence of thyroid cancer in the Commonwealth of Pennsylvania. JAMA Otolaryngol Head Neck Surg 140(12):1149–1156
Ramirez-Vick M, Nieves-Rodriguez M, Lugaro-Gomez A, Perez-Irizarry J (2011) Increasing incidence of thyroid cancer in Puerto Rico 1985–2004. P R Health Sci J 30(3):109–115
Amphlett B, Lawson Z, Abdulrahman GO Jr, White C, Bailey R, Premawardhana L, Okosieme OE (2013) Recent trends in the incidence geographical distribution and survival from thyroid cancer in Wales 1985–2010. Thyroid 23(11):1470–1478
Pazaitou-Panayiotou K, Iliadou P, Chrisoulidou A, Mitsakis P, Doumala E, Fotareli A, Boudina M, Mathiopoulou L, Patakiouta F, Tziomalos K (2013) The increase in thyroid cancer incidence is not only due to papillary microcarcinomas: a 40-year study in 1 778 patients. Exp Clin Endocrinol Diabetes 121(7):397–401
Xie S, Chen J, Zhang B, Wang F, Li S, Xie C, Tse L, Cheng J (2014) Time trends and age-period-cohort analyses on incidence rates of thyroid cancer in Shanghai and Hong Kong. BMC Cancer 14:975
Sokouti M, Montazeri V, Fakhrjou A, Samankan S, Goldust M (2013) Thyroid cancer clinical and histopathological study on patients under 25 years in Tabriz Iran (2000–2012). Pak J Biol Sci 16(24):2003–2008
Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, Rothman N, Zhang Y (2009) International patterns and trends in thyroid cancer incidence 1973–2002. Cancer Causes Control 20(5):525–531
Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol
Burgess JR. Skabo S, McArdle K, Tucker P (2002) Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997). Thyroid 12(2):141–149
Leenhardt L, Grosclaude P, Chérié-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14(12):1056–1060
Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317(13):1338–1348
Londero SC, Krogdahl A, Bastholt L, Overgaard J, Pedersen HB, Frisch T, Bentzen J, Pedersen PU, Christiansen P, Godballe C (2010) Papillary thyroid carcinoma in Denmark 1996–2008: an investigation of changes in incidence. Am J Surg 200(4):462–466
Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (2007) Cancer Incidence in Five Continents vol IX No 160. IARC Scientific Publications, Lyon
Parkin DM, Whelan SL, Ferlay J, Storm H (2005) Cancer Incidence in Five Continents vol I to VIII No 7. IARC CancerBase, Lyon
WHO Cancer Mortality Database (2016) World Health Organization International Agency for Research on Cancer. Accessed 16 December 2016
Verkooijen H, Fioretta G, Pache J, Franceschi S, Raymond L, Schubert H, Bouchardy C (2003) Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14(1):13–17
Montanaro F, Pury P, Bordoni A, Lutz JM, Swiss Cancer Registries Network (2006) Unexpected additional increase in the incidence of thyroid cancer among a recent birth cohort in Switzerland. Eur J Cancer Prev 15(2):178–186
Aschebrook-Kilfoy B, DellaValle C, Purdue M, Kim C, Zhang Y, Sjodin A, Ward M (2015) Polybrominated diphenyl ethers and thyroid cancer risk in the prostate colorectal lung and ovarian cancer screening trial cohort. Am J Epidemiol 181(11):883–888
Zeng Q, Chen CG, Vlantis A, van Hasselt C (2007) Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif 40(6):921–935
Chen G, Vlantis A, Zeng Q, van Hasselt C (2008) Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr Cancer Drug Targets 8(5):367–377
Kumar A, Klinge C, Goldstein R (2010) Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. Int J Oncol 36(5):1067–1080
Rajoria S, Suriano R, Shanmugam A, Wilson Y, Schantz SP, Geliebter J, Tiwari R (2010) Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid 20(1):33–41
Derwahl M, Nicula D (2014) Estrogen and its role in thyroid cancer. Endocr Relat Cancer 21(5):T273–T283
Shindo H, Amino N, Ito Y, Kihara M, Kobayashi K, Miya A, Hirokawa M, MIyauchi A (2014) Papillary thyroid microcarcinoma might progress during pregnancy. Thyroid 24(5):840–844
Messuti I, Corvisieri S, Bardesono F, Rapa I, Giorcelli J, Pellerito R, Volante M, Orlandi F (2014) Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features. Eur J Endocrinol 170(5):659–666
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
James, B.C., Mitchell, J.M., Jeon, H.D. et al. An update in international trends in incidence rates of thyroid cancer, 1973–2007. Cancer Causes Control 29, 465–473 (2018). https://doi.org/10.1007/s10552-018-1023-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-018-1023-2